Skip to main content
Premium Trial:

Request an Annual Quote

Panvera Eyes European Expansion

TORONTO, June 11 - Panvera is looking to expand to Europe, a company official told GenomeWeb today.

 

President Mike Wokasch said Panvera hopes to have at least two people on the ground in Europe, possibly the UK, within a year to help the company sell its protein drug targets and its drug-screening essays, and also to provide tech support.

 

"Europe represents a significant growth opportunity for us," said Wokasch, who was tapped in March to run Vertex's other unit, Aurora Biosciences. He made his comments during lunch with a GenomeWeb reporter in between sessions at the BIO 2002 conference here, which ends tomorrow.

 

He said Madison, Wisc.-based Panvera is "debating" whether to hire locally or to plant a current US-based staffer.

 

Aurora, a San Diego-based biotech concern, acquired Panvera in March 2001. One month later Vertex gobbled up Aurora.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.